-
Glucan
Laminarin (500 micrograms/ml) was added to DCs in order to block their beta-glucan receptors.
-
Molecular entity
We used a MHC II presentation pathway targeting vector originally published by Wang et al. 1999 for the delivery of antigens in both murine and human DC.
-
curdlan
Using curdlan as a specific agonist of dectin-1, we have shown that this C-type lectin couple to Syk kinase leads to activation of ERK, JNK and p38 MAPKs, as well as NF-kappaB.
-
vaccine
DC based vaccines expressing the tumor antigens PSA or Her2/neu were produced in a pre-clinical work.
-
T cell receptor
These TcR-Tg clones are specific for the P14-GP33 antigen.
In the individual T cells, we studied the expression of twenty different genes either mediating effector functions, or coding for different receptors involved in T cell differentiation and memory generation.
-
T cell receptor
The TcR-Tg clones are specific for the 0T-1-OVA antigen.
In the individual T cells, we studied the expression of twenty different genes either mediating effector functions, or coding for different receptors involved in T cell differentiation and memory generation.
-
CD1d molecule
CD1 molecules that are subsequently to be refolded in vitro in order to generate CD1 tetramers.
-
Molecular entity
TLR ligands (simultaneous activation of TLR4 and TLR8 signaling cascades) were used as stimuli for MDDC and resulted in a marked inhibition of the secretion of the proinflammatory chemokine CCL2 with respect to stimulation through a single TLR.
-
vaccine
The autologous, apoptotic, leukemic cells (Apo-DC) vaccine was given to 2 cohorts of patients: without additional adjuvants and with GM-CSF as an adjuvant. These two cohorts were monitored for 52 weeks. The clinical and immune monitoring data is being currently analyzed.
-
CD1d molecule
CD1 molecules are refolded in vitro in order to generate CD1 tetramers.
-
vaccine
The protein vaccines were injected combined with a combination of iNKT cell-agonist alpha-GalCer and MPL, a detoxified version of LPS that signals through TLR4. This combination treatment stimulates antigen-specific T and B cell responses that are greater than those elicited with alpha-GalCer or MPL alone.
-
protein
The CD1d tetramers were generated from in vitro refolded CD1 molecules. The ability to generate CD1d tetramers has provided us with the opportunity of comparing a broad panel of CD1d binding compounds for their ability to stimulate iNKT cells.
-
ribonucleic acids
Yeast RNA (along with R848, Curdland, LPS and yeast cells in different conditions of culture) was used to induce DC activation.
-
resiquimod
R848 (along with LPS, Curdlan, yeast RNA and yeast cells in different conditions of culture) was used to induce DC activation.
-
Tumor necrosis factor alpha
TNF-alpha is used during maturation of the DCs.
-
streptomycin
50 mg/ml of streptomycin (Gibco BRL) containing 10% (vol/vol) FCS (Hyclone) were added to the monocyte cell culture.
-
penicillin
50 U/ml of penicillin were added to the monocyte cell culture.
-
sodium pyruvate
100 mM sodium pyruvate were added to the monocyte cell culture.
-
amino acids
1% (vol/vol) non-essential amino acids were added to the monocyte cell culture.
-
L-Glutamine
2 mM L-glutamine (Sigma) was added to the monocyte cell culture.